Cynthia I Campbell1,2, Andrea H Kline-Simon1, Michael Von Korff3, Kathleen W Saunders3, Constance Weisner1,2. 1. a Kaiser Permanente Northern California , Oakland , California , USA. 2. b Department of Psychiatry , University of California San Francisco , San Francisco , California , USA. 3. c Kaiser Permanente Washington Health Research Institute , Seattle , Washington , USA.
Abstract
OBJECTIVE: To better identify individuals on chronic opioid therapy (COT) at high risk for aberrant-drug related behavior (ADRB). We examine whether patients with low level alcohol and drug use have similar characteristics to those with alcohol and drug disorders. We then examined the relationship of alcohol and drug use to ADRBs among COT patients. METHODS: The sample was 972 randomly selected COT patients (age 21-80 years old) from a large health system in Northern California, USA, and interviewed in 2009. Logistic regression models were used to model the dependent variables of: alcohol use, illicit drug use, alcohol disorders, illicit drug disorders, and ADRBs. RESULTS: The odds of daily/weekly alcohol use were lower for those with a high daily opioid dose (120+ mg/day vs. <20 mg/day) (OR = 0.32, p < 0.010). Illicit drug disorders were associated with depression (OR = 2.31, p < .001) and being on a high daily opioid dose (OR = 5.51, p < .01). Participants with illicit drug use had higher odds of giving (OR = 2.57, p < 0.01) and receiving opioids from friends or family (OR = 3.25, p < 0.001), but disorder diagnoses were not associated with ADRBs. CONCLUSIONS: Findings reinforce that illicit drug use should be of high concern to clinicians prescribing opioids, and suggest it should be considered separately from alcohol use and alcohol disorders in the evaluation of ADRBs. Frequent alcohol use is low, but not uncommon, and suggests a need to discuss specific issues regarding safe use of opioids among persons who use alcohol that may differ from their risk of drug use.
OBJECTIVE: To better identify individuals on chronic opioid therapy (COT) at high risk for aberrant-drug related behavior (ADRB). We examine whether patients with low level alcohol and drug use have similar characteristics to those with alcohol and drug disorders. We then examined the relationship of alcohol and drug use to ADRBs among COT patients. METHODS: The sample was 972 randomly selected COT patients (age 21-80 years old) from a large health system in Northern California, USA, and interviewed in 2009. Logistic regression models were used to model the dependent variables of: alcohol use, illicit drug use, alcohol disorders, illicit drug disorders, and ADRBs. RESULTS: The odds of daily/weekly alcohol use were lower for those with a high daily opioid dose (120+ mg/day vs. <20 mg/day) (OR = 0.32, p < 0.010). Illicit drug disorders were associated with depression (OR = 2.31, p < .001) and being on a high daily opioid dose (OR = 5.51, p < .01). Participants with illicit drug use had higher odds of giving (OR = 2.57, p < 0.01) and receiving opioids from friends or family (OR = 3.25, p < 0.001), but disorder diagnoses were not associated with ADRBs. CONCLUSIONS: Findings reinforce that illicit drug use should be of high concern to clinicians prescribing opioids, and suggest it should be considered separately from alcohol use and alcohol disorders in the evaluation of ADRBs. Frequent alcohol use is low, but not uncommon, and suggests a need to discuss specific issues regarding safe use of opioids among persons who use alcohol that may differ from their risk of drug use.
Entities:
Keywords:
Alcohol use; aberrant drug related behavior; alcohol disorder; chronic opioid therapy; drug disorder; drug use
Authors: Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner Journal: J Pain Date: 2012-01-29 Impact factor: 5.820
Authors: Michael Von Korff; Paul Crane; Michael Lane; Diana L Miglioretti; Greg Simon; Kathleen Saunders; Paul Stang; Nancy Brandenburg; Ronald Kessler Journal: Pain Date: 2005-02 Impact factor: 6.961
Authors: Jessica S Merlin; Janet M Turan; Ivan Herbey; Andrew O Westfall; Joanna L Starrels; Stefan G Kertesz; Michael S Saag; Christine S Ritchie Journal: Pain Med Date: 2014-08-19 Impact factor: 3.750
Authors: Daniel E Jonas; James C Garbutt; Halle R Amick; Janice M Brown; Kimberly A Brownley; Carol L Council; Anthony J Viera; Tania M Wilkins; Cody J Schwartz; Emily M Richmond; John Yeatts; Tammeka Swinson Evans; Sally D Wood; Russell P Harris Journal: Ann Intern Med Date: 2012-11-06 Impact factor: 25.391
Authors: Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner Journal: Clin J Pain Date: 2008 Jul-Aug Impact factor: 3.442
Authors: K L Lentine; N N Lam; A S Naik; D A Axelrod; Z Zhang; V R Dharnidharka; G P Hess; D L Segev; R Ouseph; H Randall; T Alhamad; R Devraj; R Gadi; B L Kasiske; D C Brennan; M A Schnitzler Journal: Am J Transplant Date: 2018-04-17 Impact factor: 8.086
Authors: Krista L Lentine; Kevin S Shah; Jon A Kobashigawa; Huiling Xiao; Zidong Zhang; David A Axelrod; Ngan N Lam; Dorry L Segev; Mara Ann McAdams-DeMarco; Henry Randall; Gregory P Hess; Hui Yuan; Luke S Vest; Bertram L Kasiske; Mark A Schnitzler Journal: Am J Transplant Date: 2019-09-12 Impact factor: 8.086
Authors: Elizabeth Charron; Akiko Okifuji; M Aryana Bryan; Sarah Reese; Jennifer L Brown; Andrew Ferguson; Udi E Ghitza; T Winhusen; Gerald Cochran Journal: J Pain Date: 2022-04-11 Impact factor: 5.383
Authors: Krista L Lentine; Paolo R Salvalaggio; Yasar Caliskan; Ngan N Lam; Mara McAdams-DeMarco; David Axelrod; Dorry L Segev; Larissa Myaskovsky; Mary Amanda Dew; Heather Bruschwein; Deborah J Levine; Stuart Sweet; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler Journal: J Heart Lung Transplant Date: 2021-02-17 Impact factor: 13.569